Enzyte

Enzyte is an herbal dietary supplement originally produced by Berkeley Premium Nutraceuticals, later taken over by Vianda, LLC, based in Cincinnati, Ohio. It has been marketed as a means to "promote natural male enhancement," which is essentially a euphemism for the enlargement of the penis. Yet, its true efficacy has been a matter of contention, and the claims made by its manufacturers have been closely inspected by multiple state and federal entities.

Claims and Controversies

Efficacy Doubts

Despite the extensive marketing efforts put behind Enzyte, several medical professionals have expressed skepticism about its effectiveness. Notably, Dr. Kenneth Goldberg, the medical director of the Male Health Center at Baylor University, has stated, "Medically, Enzyte's claims are baseless. Simply increasing blood flow to the penis, as the product claims, would not result in an increase in its size."

Legal Troubles

In 2005, after numerous complaints were filed with the Better Business Bureau, federal agents executed a search on Berkeley facilities. This raid eventually led to a 112-count criminal indictment. Both the founder and CEO, Steve Warshak, alongside his mother, Harriet Warshak, were convicted on various charges including conspiracy to commit mail fraud, bank fraud, and money laundering. Consequently, in September 2008, they were both incarcerated and mandated to forfeit assets worth $500 million. Due to these penalties, the company had to declare bankruptcy, and in December of the same year, its assets, worth $2.75 million, were acquired by investment firm Pristine Bay.

Marketing Evolution

By 2009, the marketing strategy of Enzyte shifted towards addressing erectile dysfunction to appeal to a broader consumer base. It was frequently advertised on U.S. television networks as "the once-daily tablet for natural male enhancement." Their advertisements were characterized by the figure "Smilin' Bob," whose perpetual smile was suggested to be an outcome of using Enzyte. These commercials were notorious for their suggestive double entendres, with some also featuring a similarly cheerful "Mrs. Bob."

Regulatory Landscape

As Enzyte is classified as an herbal supplement, it does not necessitate testing or approval by the U.S. Food and Drug Administration (FDA). However, representatives from federal institutions have voiced concerns regarding the lack of scientific backing for Enzyte. One official from the Federal Trade Commission's advertising monitoring division commented on the absence of scientific evaluations as being "an immediate red flag." The manufacturing company has admitted to not possessing any scientific studies that corroborate any of Enzyte's claims.

Dr. Ira Sharlip, speaking on behalf of the American Urological Association, clearly stated, "Penis pills like these simply do not work. They are commercial products marketed for profit, devoid of any scientific basis or proven efficacy."

Conclusion

While Enzyte has been extensively promoted and has enjoyed considerable market visibility, questions regarding its effectiveness, coupled with significant legal and regulatory challenges, have cast doubts on its claims and the ethics of its promotion. As with all supplements, potential users are advised to approach with caution and consult with medical professionals before usage.

See also

• Erectile dysfunction
• ExtenZe
• Penis enlargement
• Patent medicine

External links

• Enzyte website
• USAToday – Why is this man smiling? It's not Viagra

File:WHO Rod.svg This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia